U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H25NO2S
Molecular Weight 355.494
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JX-401

SMILES

COC1=CC(SC)=CC=C1C(=O)N2CCC(CC3=CC=CC=C3)CC2

InChI

InChIKey=OMGLGPKQUFSRNN-UHFFFAOYSA-N
InChI=1S/C21H25NO2S/c1-24-20-15-18(25-2)8-9-19(20)21(23)22-12-10-17(11-13-22)14-16-6-4-3-5-7-16/h3-9,15,17H,10-14H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C21H25NO2S
Molecular Weight 355.494
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://encrypted.google.com/patents/WO2012154814A1 | https://encrypted.google.com/patents/WO2006018842A3

JX-401 is potent, reversible inhibitor of p38α that displays no activity on the p38γ isoform. JX-401 is effective in mammalian cells, as it blocks the differentiation of myoblasts into myotubes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
32.2 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
JX401, A p38alpha inhibitor containing a 4-benzylpiperidine motif, identified via a novel screening system in yeast.
2006 Oct
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
L8 myoblasts were grown in growth medium (15% bovine calf serum in Dulbecco’s modified Eagle’s medium). For induction of differentiation, the medium was changed to differentiation medium (no serum, 10 mkg/ml insulin, and transferrin in Dulbecco’s modified Eagle’s medium) when the culture became confluent. JX401, and its various derivatives were dissolved in dimethyl sulfoxide (DMSO) to a concentration of 10 mM. Aliquots from these stocks were added directly to differentiation medium to obtain a final concentration of 10 mkM. Control cells were incubated with the same volumes of DMSO without the inhibitors. The growth medium was replaced, and fresh inhibitors were added every 24 h. Preparation of lysates of L8 cells was performed as described previously. For monitoring myogenin induction, 40 mkg of lysates were separated by SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose and probed with anti-myogenin monoclonal antibodies.
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:59:47 GMT 2023
Edited
by admin
on Sat Dec 16 07:59:47 GMT 2023
Record UNII
TBU7UTV30Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
JX-401
Common Name English
METHANONE, (2-METHOXY-4-(METHYLTHIO)PHENYL)(4-(PHENYLMETHYL)-1-PIPERIDINYL)-
Systematic Name English
PIPERIDINE, 1-(2-METHOXY-4-(METHYLTHIO)BENZOYL)-4-(PHENYLMETHYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
TBU7UTV30Q
Created by admin on Sat Dec 16 07:59:47 GMT 2023 , Edited by admin on Sat Dec 16 07:59:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID20360557
Created by admin on Sat Dec 16 07:59:47 GMT 2023 , Edited by admin on Sat Dec 16 07:59:47 GMT 2023
PRIMARY
CAS
349087-34-9
Created by admin on Sat Dec 16 07:59:47 GMT 2023 , Edited by admin on Sat Dec 16 07:59:47 GMT 2023
PRIMARY
PUBCHEM
1126109
Created by admin on Sat Dec 16 07:59:47 GMT 2023 , Edited by admin on Sat Dec 16 07:59:47 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY